Legend Biotech Corp (LEGN)
40.94
+1.19
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
40.95
+0.01
(+0.02%)
After-Hours: 20:00
Legend Biotech Gross Profit Margin (Quarterly): 65.38% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 65.38% |
| June 30, 2024 | 72.95% |
| March 31, 2024 | 41.76% |
| December 31, 2023 | 59.16% |
| September 30, 2023 | 54.72% |
| Date | Value |
|---|---|
| June 30, 2023 | 55.45% |
| March 31, 2023 | 1.99% |
| December 31, 2022 | 16.90% |
| September 30, 2022 | 6.95% |
| June 30, 2022 | -41.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-41.50%
Minimum
Jun 2022
72.95%
Maximum
Jun 2024
33.37%
Average
48.24%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 69.01% |
| Ligand Pharmaceuticals Inc | 95.27% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 77.14% |
| IGC Pharma Inc | 48.06% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.87% |
| Return on Assets | -19.35% |
| Return on Invested Capital | -23.33% |
| Profit Margin (Quarterly) | -78.23% |
| Operating Margin (Quarterly) | -43.73% |
| Return on Net Operating Assets | -43.69% |